BIO vs UNIT · rev $2.58B vs P/E 2.7, rev $722.6M
BIO (BIO) versus Uniti Group Inc (UNIT) — a side-by-side from cached financials, not a winner call.
BIO (BIO) common stock.
Uniti Group Inc (UNIT) is a reit - specialty company listed on NASDAQ.
Latest reported BIO revenue for 2025-12-31 was $2.58B. Net income was $759.9M. Revenue was up 0.7% from 2024-12-31 to 2025-12-31. BIO currently screens at market cap $0.
Latest reported UNIT revenue for 2025-09-30 was $722.6M. Net income was $1.61B. Revenue was up 147.3% from 2024-09-30 to 2025-09-30. UNIT currently screens at market cap $2.96B and trailing P/E 2.7.
BIO currently screens at market cap $0. UNIT currently screens at market cap $2.96B and trailing P/E 2.7.
Not investment advice. Open the BIO and UNIT stock pages for the full models.
Not investment advice.